Global Egg Phosphatidylcholine Market Overview

Egg Phosphatidylcholine Market was valued at USD 13640 million in 2021 and is expected to reach USD 20520 million by the year 2028, at a CAGR of 6.01%.

Egg phosphatidylcholine is referred to as a major component of the biological membrane which is obtained from egg yolk through chemical or mechanical methods using hexane as a reagent. Phospholipids are a class of lipids that hold phosphorus in their molecules and can be applied as signal transmission emulsifiers, messengers, and stabilizers, and have got a great attraction in recent years owing to their biochemical properties. Phosphatidylcholine is a type of phospholipid, mainly extracted from soybean and egg and is highly used as emulsifiers in foods, pharmaceutical and cosmetic products. Phospholipids (PLs) are the major component of cell membranes and act as a key role in the biochemistry and physiology of the cell. Additionally, egg yolk lecithin carries 18% (w/w) phosphatidylethanolamine (PE), 78% (w/w) phosphatidylcholine (PC), and 2% (w/w) cholesterol. Moreover, phospholipids from natural sources comprise various acyl groups, the ratio of which depends on the source. A typical fatty acyl composition of PC secluded from egg yolk such as oleic (18:1; 32%), linoleic (18:2; 9%), stearic (18:0; 11%), and palmitic (16:0; 33%). Phosphatidylcholine from egg yolk contains mainly saturated fatty acids and no sn-3 polyunsaturated fatty acids (PUFA), which is a good model of biofilm. Furthermore, egg phosphatidylcholine is utilized in moisturizers, emulsifiers, and various creams or lotions to beautify and maintain hair and skin texture. In addition, egg phosphatidylcholine is crucial for nerve signaling, fat metabolism, and cell structure maintenance. It is used to enhance liver functionality and boost the functioning of the digestive system in elderly people. The growing old-age population is expected to turn the market growth during the forecast period.

Market Dynamics and Factors of Egg Phosphatidylcholine Market:

Drivers:

The growing strong trend for high nutritious food utilization due to the rise in health concerns among consumers should drive egg phosphatidylcholine market size. It is very effective for Alzheimer's, hepatitis C, hepatitis A, peritoneal dialysis, tardive dyskinesia, ulcerative colitis, eczema, weight loss, premenstrual syndrome, and manic-depressive illness. Dietetics is highly used and has observed growth in sales in the past few years.

Rising awareness of consumers about high-quality cosmetics and nutritious food products is anticipated to accelerate the growth of the global egg phosphatidylcholine market. Macroeconomic factors such as the high rate of urbanization, rising economy, growing per capita income, and employment rate turning the global egg phosphatidylcholine market.

Growing awareness about health hazards along with growth in the elderly population is expected to drive the market. It caters as an anti-aging supplement and can increase neuroplasticity and improve brainpower. The global old age population over 60 years was estimated at around 900 million in 2015 and is anticipated to increase by 2 billion by 2050. Elderly people are more susceptible to Alzheimer's, memory loss, liver problems, and bone disorders which may support anti-aging demand and promote egg phosphatidylcholine market demand.

Restraints:

The main restraint factor of this market is the availability of substitutes. This is affected to hamper market growth during the projected period. The accessibility of low-cost substitutes for phosphatidylcholine extraction, such as soybean, sunflower, and mustard, is the main factor that is anticipated to hinder the growth of the global market for egg phosphatidylcholine.

Market Segmentation

Based on the application, the moisturizer segment accounted for the maximum share.  The moisturizing segment dominated the market due to the high growth of the cosmetics sector. Egg phosphatidylcholine is extensively utilized in the cosmetics industry due to the emulsifying properties of topical creams. The rise in the usage of cosmetics is one of the main reasons for the growth of the moisturizer segment. Properties such as low toxicity and high skin compatibility are the factors boosting the growth of the segment during the forecast period.

Based on the end-users, the pharmaceuticals segment has dominated the market and is anticipated to continue during the forecast period. This is due to the extensive range of applications in the industry such as the treatment of neurological atherosclerosis and other neurological disorders. The presence of choline in egg phosphatidylcholine is an aid to growth in demand as there is increased consciousness of high-nutrient foods. The Cosmetics segment is expected to grow during the period due to the rise in applications of products and highly increasing industry.

Players Covered in Egg Phosphatidylcholine market are :

• Harmony Whole Foods Market (Canada)
• Avanti Polar Lipids Inc (Alabama)
• Kewpie Corporation (Japan)
• Vitamin Research Products (US)
• NOF America Corporation (US)
• Natural Factors (Canada)
• Jena Bioscience GmbH (Germany)
• Kewpie Corporation (Japan)
• Nutrasal Inc (US)
• Lipoid (Switzerland)
• Others major Players.

Regional Analysis of Egg Phosphatidylcholine Market:

In North America, the U.S. egg phosphatidylcholine market size is growing due to the presence of dietary supplement producing companies such as Covance, UL and Chubb should drive product demand. The rise in healthy food utilization among the consumers and the FDA's declaration as yolk to be a good source of protein should drive regional industry growth. Moreover, more than one-third of people in the U.S. get affected by cardiovascular disease (CVD) which causes approximately one out of three deaths. Therefore, an increase in the number of CVD among the population owing to red meat ingestion would drive product demand in diet food application.

In Europe, the region of Germany's egg phosphatidylcholine market size expects to reach above 3%. Growing anti-aging cosmetic and dietetic products demand may drive egg PC market growth. The compound is also approved in liver care programs by doctors and nutritionists turning regional product demand.

In the Asia Pacific region, China's market size is expected to increase the market owing to China and Japan have about 20 percent and 30 percent of their total population above the 55-year age and 60-year age group respectively. The rising aged population in China and Japan results in growth in skin issues and health disorders. Therefore, growth in the aging population will rise egg PC demand as a medicinal supplement to medicate various diseases.

COVID-19 Impact on Egg Phosphatidylcholine Market:

Since the COVID-19 pandemic in December 2019, the disease has spread to almost every country across the globe with the World Health Organization declaring it a public health emergency. The global influence of the coronavirus disease 2019 (COVID-19) is already starting to be felt, and will significantly affect the Egg Phosphatidylcholine market in 2020. The outbreak of COVID-19 has brought effects on various aspects, like flight cancellations; travel bans, and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency announced; huge declining of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Key Industry Developments of Egg Phosphatidylcholine Market:

• In July 2020, Alabama-based company Avanti Polar Lipids, Inc. declared it has agreed to be acquired by Croda International. It would support the expanded business and customer base.
• In April 2020, Germany-based company Jena Bioscience GmbH declared collaboration with Genoks Technology Co.Ltd. It would help to increase the business portfolio in the upcoming years.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Applcation
 3.2 By End Use

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  3.5.1 Drivers
  3.5.2 Restraints
  3.5.3 Opportunities
  3.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 4: Egg Phosphatidylcholine Market by Applcation
 4.1 Egg Phosphatidylcholine Market Overview Snapshot and Growth Engine
 4.2 Egg Phosphatidylcholine Market Overview
 4.3 Emulsifier
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size (2016-2028F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Emulsifier: Grographic Segmentation
 4.4 Solubilizer
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size (2016-2028F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Solubilizer: Grographic Segmentation
 4.5 Moisturizer
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size (2016-2028F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Moisturizer: Grographic Segmentation
 4.6 And Others
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size (2016-2028F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 And Others: Grographic Segmentation

Chapter 5: Egg Phosphatidylcholine Market by End Use
 5.1 Egg Phosphatidylcholine Market Overview Snapshot and Growth Engine
 5.2 Egg Phosphatidylcholine Market Overview
 5.3 Pharmaceuticals & Nutraceuticals
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Pharmaceuticals & Nutraceuticals: Grographic Segmentation
 5.4 Cosmetics & Personal Care
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Cosmetics & Personal Care: Grographic Segmentation
 5.5 Dietary Supplements
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Dietary Supplements: Grographic Segmentation
 5.6 And Others
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 And Others: Grographic Segmentation

Chapter 6: Company Profiles and Competitive Analysis
 6.1 Competitive Landscape
  6.1.1 Competitive Positioning
  6.1.2 Egg Phosphatidylcholine Sales and Market Share By Players
  6.1.3 Industry BCG Matrix
  6.1.4 Ansoff Matrix
  6.1.5 Egg Phosphatidylcholine Industry Concentration Ratio (CR5 and HHI)
  6.1.6 Top 5 Egg Phosphatidylcholine Players Market Share
  6.1.7 Mergers and Acquisitions
  6.1.8 Business Strategies By Top Players
 6.2 HARMONY WHOLE FOODS MARKET (CANADA)
  6.2.1 Company Overview
  6.2.2 Key Executives
  6.2.3 Company Snapshot
  6.2.4 Operating Business Segments
  6.2.5 Product Portfolio
  6.2.6 Business Performance
  6.2.7 Key Strategic Moves and Recent Developments
  6.2.8 SWOT Analysis
 6.3 AVANTI POLAR LIPIDS INC (ALABAMA)
 6.4 KEWPIE CORPORATION (JAPAN)
 6.5 VITAMIN RESEARCH PRODUCTS (US)
 6.6 NOF AMERICA CORPORATION (US)
 6.7 NATURAL FACTORS (CANADA)
 6.8 JENA BIOSCIENCE GMBH (GERMANY)
 6.9 KEWPIE CORPORATION (JAPAN)
 6.10 NUTRASAL INC (US)
 6.11 LIPOID (SWITZERLAND)
 6.12 OTHERS

Chapter 7: Global Egg Phosphatidylcholine Market Analysis, Insights and Forecast, 2016-2028
 7.1 Market Overview
 7.2 Historic and Forecasted Market Size By Applcation
  7.2.1 Emulsifier
  7.2.2 Solubilizer
  7.2.3 Moisturizer
  7.2.4 And Others
 7.3 Historic and Forecasted Market Size By End Use
  7.3.1 Pharmaceuticals & Nutraceuticals
  7.3.2 Cosmetics & Personal Care
  7.3.3 Dietary Supplements
  7.3.4 And Others

Chapter 8: North America Egg Phosphatidylcholine Market Analysis, Insights and Forecast, 2016-2028
 8.1 Key Market Trends, Growth Factors and Opportunities
 8.2 Impact of Covid-19
 8.3 Key Players
 8.4 Key Market Trends, Growth Factors and Opportunities
 8.4 Historic and Forecasted Market Size By Applcation
  8.4.1 Emulsifier
  8.4.2 Solubilizer
  8.4.3 Moisturizer
  8.4.4 And Others
 8.5 Historic and Forecasted Market Size By End Use
  8.5.1 Pharmaceuticals & Nutraceuticals
  8.5.2 Cosmetics & Personal Care
  8.5.3 Dietary Supplements
  8.5.4 And Others
 8.6 Historic and Forecast Market Size by Country
  8.6.1 U.S.
  8.6.2 Canada
  8.6.3 Mexico

Chapter 9: Europe Egg Phosphatidylcholine Market Analysis, Insights and Forecast, 2016-2028
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Applcation
  9.4.1 Emulsifier
  9.4.2 Solubilizer
  9.4.3 Moisturizer
  9.4.4 And Others
 9.5 Historic and Forecasted Market Size By End Use
  9.5.1 Pharmaceuticals & Nutraceuticals
  9.5.2 Cosmetics & Personal Care
  9.5.3 Dietary Supplements
  9.5.4 And Others
 9.6 Historic and Forecast Market Size by Country
  9.6.1 Germany
  9.6.2 U.K.
  9.6.3 France
  9.6.4 Italy
  9.6.5 Russia
  9.6.6 Spain

Chapter 10: Asia-Pacific Egg Phosphatidylcholine Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Applcation
  10.4.1 Emulsifier
  10.4.2 Solubilizer
  10.4.3 Moisturizer
  10.4.4 And Others
 10.5 Historic and Forecasted Market Size By End Use
  10.5.1 Pharmaceuticals & Nutraceuticals
  10.5.2 Cosmetics & Personal Care
  10.5.3 Dietary Supplements
  10.5.4 And Others
 10.6 Historic and Forecast Market Size by Country
  10.6.1 China
  10.6.2 India
  10.6.3 Japan
  10.6.4 Southeast Asia

Chapter 11: South America Egg Phosphatidylcholine Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Applcation
  11.4.1 Emulsifier
  11.4.2 Solubilizer
  11.4.3 Moisturizer
  11.4.4 And Others
 11.5 Historic and Forecasted Market Size By End Use
  11.5.1 Pharmaceuticals & Nutraceuticals
  11.5.2 Cosmetics & Personal Care
  11.5.3 Dietary Supplements
  11.5.4 And Others
 11.6 Historic and Forecast Market Size by Country
  11.6.1 Brazil
  11.6.2 Argentina

Chapter 12: Middle East & Africa Egg Phosphatidylcholine Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Applcation
  12.4.1 Emulsifier
  12.4.2 Solubilizer
  12.4.3 Moisturizer
  12.4.4 And Others
 12.5 Historic and Forecasted Market Size By End Use
  12.5.1 Pharmaceuticals & Nutraceuticals
  12.5.2 Cosmetics & Personal Care
  12.5.3 Dietary Supplements
  12.5.4 And Others
 12.6 Historic and Forecast Market Size by Country
  12.6.1 Saudi Arabia
  12.6.2 South Africa

Chapter 13 Investment Analysis

Chapter 14 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. EGG PHOSPHATIDYLCHOLINE MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. EGG PHOSPHATIDYLCHOLINE MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. EGG PHOSPHATIDYLCHOLINE MARKET COMPETITIVE RIVALRY
TABLE 005. EGG PHOSPHATIDYLCHOLINE MARKET THREAT OF NEW ENTRANTS
TABLE 006. EGG PHOSPHATIDYLCHOLINE MARKET THREAT OF SUBSTITUTES
TABLE 007. EGG PHOSPHATIDYLCHOLINE MARKET BY APPLCATION
TABLE 008. EMULSIFIER MARKET OVERVIEW (2016-2028)
TABLE 009. SOLUBILIZER MARKET OVERVIEW (2016-2028)
TABLE 010. MOISTURIZER MARKET OVERVIEW (2016-2028)
TABLE 011. AND OTHERS MARKET OVERVIEW (2016-2028)
TABLE 012. EGG PHOSPHATIDYLCHOLINE MARKET BY END USE
TABLE 013. PHARMACEUTICALS & NUTRACEUTICALS MARKET OVERVIEW (2016-2028)
TABLE 014. COSMETICS & PERSONAL CARE MARKET OVERVIEW (2016-2028)
TABLE 015. DIETARY SUPPLEMENTS MARKET OVERVIEW (2016-2028)
TABLE 016. AND OTHERS MARKET OVERVIEW (2016-2028)
TABLE 017. NORTH AMERICA EGG PHOSPHATIDYLCHOLINE MARKET, BY APPLCATION (2016-2028)
TABLE 018. NORTH AMERICA EGG PHOSPHATIDYLCHOLINE MARKET, BY END USE (2016-2028)
TABLE 019. N EGG PHOSPHATIDYLCHOLINE MARKET, BY COUNTRY (2016-2028)
TABLE 020. EUROPE EGG PHOSPHATIDYLCHOLINE MARKET, BY APPLCATION (2016-2028)
TABLE 021. EUROPE EGG PHOSPHATIDYLCHOLINE MARKET, BY END USE (2016-2028)
TABLE 022. EGG PHOSPHATIDYLCHOLINE MARKET, BY COUNTRY (2016-2028)
TABLE 023. ASIA PACIFIC EGG PHOSPHATIDYLCHOLINE MARKET, BY APPLCATION (2016-2028)
TABLE 024. ASIA PACIFIC EGG PHOSPHATIDYLCHOLINE MARKET, BY END USE (2016-2028)
TABLE 025. EGG PHOSPHATIDYLCHOLINE MARKET, BY COUNTRY (2016-2028)
TABLE 026. MIDDLE EAST & AFRICA EGG PHOSPHATIDYLCHOLINE MARKET, BY APPLCATION (2016-2028)
TABLE 027. MIDDLE EAST & AFRICA EGG PHOSPHATIDYLCHOLINE MARKET, BY END USE (2016-2028)
TABLE 028. EGG PHOSPHATIDYLCHOLINE MARKET, BY COUNTRY (2016-2028)
TABLE 029. SOUTH AMERICA EGG PHOSPHATIDYLCHOLINE MARKET, BY APPLCATION (2016-2028)
TABLE 030. SOUTH AMERICA EGG PHOSPHATIDYLCHOLINE MARKET, BY END USE (2016-2028)
TABLE 031. EGG PHOSPHATIDYLCHOLINE MARKET, BY COUNTRY (2016-2028)
TABLE 032. HARMONY WHOLE FOODS MARKET (CANADA): SNAPSHOT
TABLE 033. HARMONY WHOLE FOODS MARKET (CANADA): BUSINESS PERFORMANCE
TABLE 034. HARMONY WHOLE FOODS MARKET (CANADA): PRODUCT PORTFOLIO
TABLE 035. HARMONY WHOLE FOODS MARKET (CANADA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. AVANTI POLAR LIPIDS INC (ALABAMA): SNAPSHOT
TABLE 036. AVANTI POLAR LIPIDS INC (ALABAMA): BUSINESS PERFORMANCE
TABLE 037. AVANTI POLAR LIPIDS INC (ALABAMA): PRODUCT PORTFOLIO
TABLE 038. AVANTI POLAR LIPIDS INC (ALABAMA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. KEWPIE CORPORATION (JAPAN): SNAPSHOT
TABLE 039. KEWPIE CORPORATION (JAPAN): BUSINESS PERFORMANCE
TABLE 040. KEWPIE CORPORATION (JAPAN): PRODUCT PORTFOLIO
TABLE 041. KEWPIE CORPORATION (JAPAN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. VITAMIN RESEARCH PRODUCTS (US): SNAPSHOT
TABLE 042. VITAMIN RESEARCH PRODUCTS (US): BUSINESS PERFORMANCE
TABLE 043. VITAMIN RESEARCH PRODUCTS (US): PRODUCT PORTFOLIO
TABLE 044. VITAMIN RESEARCH PRODUCTS (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. NOF AMERICA CORPORATION (US): SNAPSHOT
TABLE 045. NOF AMERICA CORPORATION (US): BUSINESS PERFORMANCE
TABLE 046. NOF AMERICA CORPORATION (US): PRODUCT PORTFOLIO
TABLE 047. NOF AMERICA CORPORATION (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. NATURAL FACTORS (CANADA): SNAPSHOT
TABLE 048. NATURAL FACTORS (CANADA): BUSINESS PERFORMANCE
TABLE 049. NATURAL FACTORS (CANADA): PRODUCT PORTFOLIO
TABLE 050. NATURAL FACTORS (CANADA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. JENA BIOSCIENCE GMBH (GERMANY): SNAPSHOT
TABLE 051. JENA BIOSCIENCE GMBH (GERMANY): BUSINESS PERFORMANCE
TABLE 052. JENA BIOSCIENCE GMBH (GERMANY): PRODUCT PORTFOLIO
TABLE 053. JENA BIOSCIENCE GMBH (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. KEWPIE CORPORATION (JAPAN): SNAPSHOT
TABLE 054. KEWPIE CORPORATION (JAPAN): BUSINESS PERFORMANCE
TABLE 055. KEWPIE CORPORATION (JAPAN): PRODUCT PORTFOLIO
TABLE 056. KEWPIE CORPORATION (JAPAN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. NUTRASAL INC (US): SNAPSHOT
TABLE 057. NUTRASAL INC (US): BUSINESS PERFORMANCE
TABLE 058. NUTRASAL INC (US): PRODUCT PORTFOLIO
TABLE 059. NUTRASAL INC (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. LIPOID (SWITZERLAND): SNAPSHOT
TABLE 060. LIPOID (SWITZERLAND): BUSINESS PERFORMANCE
TABLE 061. LIPOID (SWITZERLAND): PRODUCT PORTFOLIO
TABLE 062. LIPOID (SWITZERLAND): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. OTHERS: SNAPSHOT
TABLE 063. OTHERS: BUSINESS PERFORMANCE
TABLE 064. OTHERS: PRODUCT PORTFOLIO
TABLE 065. OTHERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. EGG PHOSPHATIDYLCHOLINE MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. EGG PHOSPHATIDYLCHOLINE MARKET OVERVIEW BY APPLCATION
FIGURE 012. EMULSIFIER MARKET OVERVIEW (2016-2028)
FIGURE 013. SOLUBILIZER MARKET OVERVIEW (2016-2028)
FIGURE 014. MOISTURIZER MARKET OVERVIEW (2016-2028)
FIGURE 015. AND OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 016. EGG PHOSPHATIDYLCHOLINE MARKET OVERVIEW BY END USE
FIGURE 017. PHARMACEUTICALS & NUTRACEUTICALS MARKET OVERVIEW (2016-2028)
FIGURE 018. COSMETICS & PERSONAL CARE MARKET OVERVIEW (2016-2028)
FIGURE 019. DIETARY SUPPLEMENTS MARKET OVERVIEW (2016-2028)
FIGURE 020. AND OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 021. NORTH AMERICA EGG PHOSPHATIDYLCHOLINE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. EUROPE EGG PHOSPHATIDYLCHOLINE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. ASIA PACIFIC EGG PHOSPHATIDYLCHOLINE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. MIDDLE EAST & AFRICA EGG PHOSPHATIDYLCHOLINE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. SOUTH AMERICA EGG PHOSPHATIDYLCHOLINE MARKET OVERVIEW BY COUNTRY (2016-2028)